Search clinical trials for: Part B Open-Label Extension

Total 1038 results

Corbus Pharmaceuticals Inc.

Terminated

Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis

United States
Scion NeuroStim

Terminated

STEM-PD Open Label Extension (OLE)

Parkinson Disease | Parkinson's Disease and Parkinsonism

United States
Dogwood Therapeutics Inc.

Active, not recruiting

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Chemotherapy Induced Neuropathic Pain | Chemotherapy Induced Pain Neuropathy | Chemotherapy Induced Pain

United States
ES Therapeutics Australia Pty Ltd

Recruiting

Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy

Drug Resistant Epilepsy

Australia
Krystal Biotech, Inc.

Completed

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | Dominant Dystrophic Epidermolysis Bullosa | DEB - Dystrophic Epidermolysis Bullosa

United States

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe